Incannex Healthcare Inc.
IXHL
$0.129
-$0.002-1.53%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -32.61% | 50.26% | 117.45% | 105.67% | 155.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.75% | 593.96% | 54.28% | 63.23% | 76.79% |
| Operating Income | 22.98% | -584.65% | -53.99% | -63.23% | -76.79% |
| Income Before Tax | -12.46% | -646.56% | -54.07% | -68.89% | -79.61% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.46% | -646.56% | -54.79% | -68.89% | -79.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.46% | -646.56% | -54.79% | -68.89% | -79.61% |
| EBIT | 22.98% | -584.65% | -53.99% | -63.23% | -76.79% |
| EBITDA | 25.21% | -586.97% | -52.55% | -63.09% | -77.43% |
| EPS Basic | -1.27% | -572.21% | -44.18% | -68.89% | -74.25% |
| Normalized Basic EPS | -1.26% | -571.33% | -43.49% | -68.92% | -74.32% |
| EPS Diluted | -1.27% | -572.21% | -44.18% | -68.89% | -74.25% |
| Normalized Diluted EPS | -1.26% | -571.33% | -43.49% | -68.92% | -74.32% |
| Average Basic Shares Outstanding | 11.03% | 11.15% | 7.34% | 0.00% | 3.08% |
| Average Diluted Shares Outstanding | 11.03% | 11.15% | 7.34% | 0.00% | 3.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |